Ingliforib
Ingliforib (CP-368296) is a glycogen phosphorylase inhibitor developed for research. It exhibits antihyperglycemic effects by reducing hepatic glucose output and has demonstrated cardioprotective properties in experimental models, supporting investigations into diabetes and ischemia-reperfusion injury.
Product Specifications
CAS Number
186392-65-4
Product Name Alternative
CP 368296, CP368296, CP-368296, inhibit, Inhibitor, Ingliforib, Glycogen phosphorylase (GP), GPi 296, GPi296, GPi-296
Field of Research
Metabolism Research
Purity
99.04% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (8.74 mM) ; DMSO:125 mg/mL (272.98 mM)
Smiles
O[C@H] ([C@H] (Cc1ccccc1) NC (=O) c1cc2cc (Cl) ccc2[nH]1) C (=O) N1C[C@H] (O) [C@H] (O) C1
Molecular Formula
C23H24ClN3O5
Molecular Weight
457.91
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog